A study in Psychiatric Services in Advance finds that patients with bipolar disorder may be more apt...

The second-generation antipsychotic asenapine may help to reduce mania and the severity of illness i...

Following an acute manic episode, many patients with bipolar disorder are treated with a combination...

In a blog post today, APA CEO and Medical Director Saul Levin, M.D., M.P.A., marked the 25th anniver...

The Food and Drug Administration (FDA) last week approved Vraylar (cariprazine), a dopamine D2/D3 re...

Citicoline reduced cocaine use and was well tolerated by patients with bipolar disorder, according t...

A combination of the antipsychotic olanzapine and the antidepressant fluoxetine proved superior to p...

People with serious mental illnesses such as schizophrenia or bipolar disorder are at greater risk f...

Though research has shown some psychiatric populations to be at risk for disadvantages involving fer...